| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $50.1M | — | +1079.8% |
| Cost of Revenue | $25.5M | — | +822.7% |
| Gross Profit | $24.7M | — | +1556.5% |
| R&D Expense | $13.5M | — | +290.8% |
| SG&A Expense | $43.3M | — | +633.0% |
| Operating Income | -$42.7M | — | -313.9% |
| Pre-tax Income | $361.5M | — | +2657.2% |
| Income Tax | $245K | — | — |
| Net Income | $362.8M | — | +2666.4% |
| EPS (Basic) | $0.58 | — | +486.7% |
| EPS (Diluted) | $0.56 | — | +473.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.03B | +86.3% | — |
| Short-term Investments | $447.8M | +1959.0% | — |
| Accounts Receivable | $45.3M | +102.6% | +2266.8% |
| Inventory | $34.3M | +56.1% | +225.0% |
| Current Assets | $1.63B | +137.5% | +3654.2% |
| Total Assets | $2.44B | +115.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$51.3M | — | -670.3% |
| Capital Expenditures | $1.3M | — | +679.6% |
| Investing Cash Flow | -$474.2M | — | — |
| Financing Cash Flow | $968.5M | — | — |
| Free Cash Flow | -$52.6M | — | -670.6% |
| +2232.1% |
| Current Liabilities | $149.3M | +5.3% | +196.2% |
| Total Liabilities | $1.36B | +105.5% | +2245.2% |
| Stockholders' Equity | $1.07B | +145.3% | +4017.9% |